HEADER HYDROLASE 25-JUL-03 1Q2Q TITLE ENTEROBACTER CLOACAE GC1 CLASS C BETA-LACTAMASE COMPLEXED WITH PENEM TITLE 2 WAY185229 COMPND MOL_ID: 1; COMPND 2 MOLECULE: CLASS C BETA-LACTAMASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: PENICILLINASE; COMPND 5 SYNONYM: BETA-LACTAMASE AMPCPIT-2; COMPND 6 EC: 3.5.2.6; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROBACTER CLOACAE; SOURCE 3 ORGANISM_TAXID: 550; SOURCE 4 GENE: BLA; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: AS226-51; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PHSG398 KEYWDS HYDROLASE, INHIBITION, BETA-LACTAM ANTIBIOTICS, DRUG DESIGN EXPDTA X-RAY DIFFRACTION AUTHOR M.NUKAGA,A.M.VENKATESAN,T.S.MANSOUR,A.HUJER,R.A.BONOMO,J.R.KNOX REVDAT 8 20-NOV-24 1Q2Q 1 REMARK REVDAT 7 16-AUG-23 1Q2Q 1 REMARK REVDAT 6 24-JUL-19 1Q2Q 1 REMARK LINK REVDAT 5 16-NOV-11 1Q2Q 1 HETATM REVDAT 4 13-JUL-11 1Q2Q 1 VERSN REVDAT 3 24-FEB-09 1Q2Q 1 VERSN REVDAT 2 15-FEB-05 1Q2Q 1 JRNL AUTHOR REVDAT 1 14-SEP-04 1Q2Q 0 JRNL AUTH A.M.VENKATESAN,Y.GU,O.DOS SANTOS,T.ABE,A.AGARWAL,Y.YANG, JRNL AUTH 2 P.J.PETERSEN,W.J.WEISS,T.S.MANSOUR,M.NUKAGA,A.HUJER, JRNL AUTH 3 R.A.BONOMO,J.R.KNOX JRNL TITL STRUCTURE-ACTIVITY RELATIONSHIP OF 6-METHYLIDENE PENEMS JRNL TITL 2 BEARING TRICYCLIC HETEROCYCLES AS BROAD-SPECTRUM JRNL TITL 3 BETA-LACTAMASE INHIBITORS: CRYSTALLOGRAPHIC STRUCTURES SHOW JRNL TITL 4 UNEXPECTED BINDING OF 1,4-THIAZEPINE INTERMEDIATES JRNL REF J.MED.CHEM. V. 47 6556 2004 JRNL REFN ISSN 0022-2623 JRNL PMID 15588091 JRNL DOI 10.1021/JM049680X REMARK 2 REMARK 2 RESOLUTION. 1.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : SHELXL-97 REMARK 3 AUTHORS : G.M.SHELDRICK REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.4 REMARK 3 CROSS-VALIDATION METHOD : FREE R REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (NO CUTOFF). REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : 0.145 REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : 0.144 REMARK 3 FREE R VALUE (NO CUTOFF) : 0.209 REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : 1861 REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 62428 REMARK 3 REMARK 3 FIT/AGREEMENT OF MODEL FOR DATA WITH F>4SIG(F). REMARK 3 R VALUE (WORKING + TEST SET, F>4SIG(F)) : 0.126 REMARK 3 R VALUE (WORKING SET, F>4SIG(F)) : 0.172 REMARK 3 FREE R VALUE (F>4SIG(F)) : 0.203 REMARK 3 FREE R VALUE TEST SET SIZE (%, F>4SIG(F)) : 3.000 REMARK 3 FREE R VALUE TEST SET COUNT (F>4SIG(F)) : 1497 REMARK 3 TOTAL NUMBER OF REFLECTIONS (F>4SIG(F)) : 50322 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2753 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 29 REMARK 3 SOLVENT ATOMS : 452 REMARK 3 REMARK 3 MODEL REFINEMENT. REMARK 3 OCCUPANCY SUM OF NON-HYDROGEN ATOMS : 3246.1 REMARK 3 OCCUPANCY SUM OF HYDROGEN ATOMS : 2673.0 REMARK 3 NUMBER OF DISCRETELY DISORDERED RESIDUES : 19 REMARK 3 NUMBER OF LEAST-SQUARES PARAMETERS : 30061 REMARK 3 NUMBER OF RESTRAINTS : 37045 REMARK 3 REMARK 3 RMS DEVIATIONS FROM RESTRAINT TARGET VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 ANGLE DISTANCES (A) : 0.026 REMARK 3 SIMILAR DISTANCES (NO TARGET VALUES) (A) : 0.000 REMARK 3 DISTANCES FROM RESTRAINT PLANES (A) : 0.029 REMARK 3 ZERO CHIRAL VOLUMES (A**3) : 0.065 REMARK 3 NON-ZERO CHIRAL VOLUMES (A**3) : 0.066 REMARK 3 ANTI-BUMPING DISTANCE RESTRAINTS (A) : 0.016 REMARK 3 RIGID-BOND ADP COMPONENTS (A**2) : 0.003 REMARK 3 SIMILAR ADP COMPONENTS (A**2) : 0.049 REMARK 3 APPROXIMATELY ISOTROPIC ADPS (A**2) : 0.085 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED: NULL REMARK 3 REMARK 3 STEREOCHEMISTRY TARGET VALUES : ENGH & HUBER REMARK 3 SPECIAL CASE: NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1Q2Q COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-JUL-03. REMARK 100 THE DEPOSITION ID IS D_1000019841. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 24-JUN-02 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : CHESS REMARK 200 BEAMLINE : A1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9474 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 62479 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.400 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.7 REMARK 200 DATA REDUNDANCY : 4.300 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.12600 REMARK 200 FOR THE DATA SET : 7.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.45 REMARK 200 COMPLETENESS FOR SHELL (%) : 79.6 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.40900 REMARK 200 FOR SHELL : 2.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY 1GCE REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, HEPES, PH 7.0, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 38.11150 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 34.52300 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 38.11150 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 34.52300 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 945 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 VAL A 214 REMARK 465 SER A 215 REMARK 465 PRO A 216 REMARK 465 GLY A 217 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 37 NZ REMARK 470 LYS A 52 NZ REMARK 470 LYS A 143 NZ REMARK 470 LYS A 293 CD CE NZ REMARK 470 LYS A 312 CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG A 213 C ARG A 213 O 0.146 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 133 CD - NE - CZ ANGL. DEV. = 25.8 DEGREES REMARK 500 ARG A 133 CD - NE - CZ ANGL. DEV. = 9.0 DEGREES REMARK 500 ARG A 204 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG A 210 NE - CZ - NH2 ANGL. DEV. = -5.4 DEGREES REMARK 500 ARG A 213 CA - C - O ANGL. DEV. = -15.5 DEGREES REMARK 500 GLN A 222 CA - CB - CG ANGL. DEV. = 14.5 DEGREES REMARK 500 ARG A 264 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 264 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 GLU A 288 OE1 - CD - OE2 ANGL. DEV. = -8.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TRP A 93 76.22 -151.46 REMARK 500 SER A 154 -66.13 -90.68 REMARK 500 ILE A 189 -66.38 -90.67 REMARK 500 TYR A 224 11.35 -155.50 REMARK 500 ASN A 344 41.77 -102.44 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE WY2 A 400 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 410 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1Q2P RELATED DB: PDB REMARK 900 KLEBSIELLA PNEUMONIAE SHV-1 CLASS A BETA-LACTAMASE COMPLEXED WITH REMARK 900 PENEM WAY185229 REMARK 900 RELATED ID: 1SHV RELATED DB: PDB REMARK 900 STRUCTURE OF SHV-1 BETA-LACTAMASE REMARK 900 RELATED ID: 1ONG RELATED DB: PDB REMARK 900 SHV-1 BETA-LACTAMASE COMPLEXED WITH PENEM WAY185489 REMARK 900 RELATED ID: 1ONH RELATED DB: PDB REMARK 900 ENTEROBACTER CLOACAE GC1 CLASS C BETA-LACTAMASE COMPLEXED WITH REMARK 900 PENEM WAY185489 DBREF 1Q2Q A 2 364 UNP Q59401 Q59401_ENTCL 22 384 SEQRES 1 A 363 PRO VAL SER GLU LYS GLN LEU ALA GLU VAL VAL ALA ASN SEQRES 2 A 363 THR VAL THR PRO LEU MET LYS ALA GLN SER VAL PRO GLY SEQRES 3 A 363 MET ALA VAL ALA VAL ILE TYR GLN GLY LYS PRO HIS TYR SEQRES 4 A 363 TYR THR PHE GLY LYS ALA ASP ILE ALA ALA ASN LYS PRO SEQRES 5 A 363 VAL THR PRO GLN THR LEU PHE GLU LEU GLY SER ILE SER SEQRES 6 A 363 LYS THR PHE THR GLY VAL LEU GLY GLY ASP ALA ILE ALA SEQRES 7 A 363 ARG GLY GLU ILE SER LEU ASP ASP PRO VAL THR ARG TYR SEQRES 8 A 363 TRP PRO GLN LEU THR GLY LYS GLN TRP GLN GLY ILE ARG SEQRES 9 A 363 MET LEU ASP LEU ALA THR TYR THR ALA GLY GLY LEU PRO SEQRES 10 A 363 LEU GLN VAL PRO ASP GLU VAL THR ASP ASN ALA SER LEU SEQRES 11 A 363 LEU ARG PHE TYR GLN ASN TRP GLN PRO GLN TRP LYS PRO SEQRES 12 A 363 GLY THR THR ARG LEU TYR ALA ASN ALA SER ILE GLY LEU SEQRES 13 A 363 PHE GLY ALA LEU ALA VAL LYS PRO SER GLY MET PRO TYR SEQRES 14 A 363 GLU GLN ALA MET THR THR ARG VAL LEU LYS PRO LEU LYS SEQRES 15 A 363 LEU ASP HIS THR TRP ILE ASN VAL PRO LYS ALA GLU GLU SEQRES 16 A 363 ALA HIS TYR ALA TRP GLY TYR ARG ASP GLY LYS ALA VAL SEQRES 17 A 363 ARG ALA VAL ARG VAL SER PRO GLY MET LEU ASP ALA GLN SEQRES 18 A 363 ALA TYR GLY VAL LYS THR ASN VAL GLN ASP MET ALA ASN SEQRES 19 A 363 TRP VAL MET ALA ASN MET ALA PRO GLU ASN VAL ALA ASP SEQRES 20 A 363 ALA SER LEU LYS GLN GLY ILE ALA LEU ALA GLN SER ARG SEQRES 21 A 363 TYR TRP ARG ILE GLY SER MET TYR GLN GLY LEU GLY TRP SEQRES 22 A 363 GLU MET LEU ASN TRP PRO VAL GLU ALA ASN THR VAL VAL SEQRES 23 A 363 GLU GLY SER ASP SER LYS VAL ALA LEU ALA PRO LEU PRO SEQRES 24 A 363 VAL ALA GLU VAL ASN PRO PRO ALA PRO PRO VAL LYS ALA SEQRES 25 A 363 SER TRP VAL HIS LYS THR GLY SER THR GLY GLY PHE GLY SEQRES 26 A 363 SER TYR VAL ALA PHE ILE PRO GLU LYS GLN ILE GLY ILE SEQRES 27 A 363 VAL MET LEU ALA ASN THR SER TYR PRO ASN PRO ALA ARG SEQRES 28 A 363 VAL GLU ALA ALA TYR HIS ILE LEU GLU ALA LEU GLN HET WY2 A 400 43 HET GOL A 410 6 HETNAM WY2 (6,7-DIHYDRO-5H-CYCLOPENTA[D]IMIDAZO[2,1-B]THIAZOL-2- HETNAM 2 WY2 YL]-4,7-DIHYDRO[1,4]THIAZEPINE-3,6-DICARBOXYLIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 WY2 C15 H13 N3 O4 S2 FORMUL 3 GOL C3 H8 O3 FORMUL 4 HOH *452(H2 O) HELIX 1 1 SER A 4 GLN A 23 1 20 HELIX 2 2 ILE A 65 ARG A 80 1 16 HELIX 3 3 PRO A 88 TRP A 93 5 6 HELIX 4 4 GLY A 98 GLN A 102 5 5 HELIX 5 5 ARG A 105 TYR A 112 1 8 HELIX 6 6 ASP A 127 TRP A 138 1 12 HELIX 7 7 ALA A 151 VAL A 163 1 13 HELIX 8 8 PRO A 169 VAL A 178 1 10 HELIX 9 9 PRO A 192 TYR A 199 5 8 HELIX 10 10 LEU A 219 GLY A 225 1 7 HELIX 11 11 ASN A 229 ALA A 242 1 14 HELIX 12 12 PRO A 243 VAL A 246 5 4 HELIX 13 13 ASP A 248 GLN A 259 1 12 HELIX 14 14 GLU A 282 ASP A 291 1 10 HELIX 15 15 ASP A 291 LEU A 296 1 6 HELIX 16 16 PRO A 348 ALA A 362 1 15 SHEET 1 A10 LYS A 52 PRO A 53 0 SHEET 2 A10 LYS A 37 ASP A 47 -1 N ASP A 47 O LYS A 52 SHEET 3 A10 GLY A 27 TYR A 34 -1 N VAL A 30 O TYR A 41 SHEET 4 A10 ILE A 337 ALA A 343 -1 O GLY A 338 N ILE A 33 SHEET 5 A10 GLY A 326 ILE A 332 -1 N ALA A 330 O ILE A 339 SHEET 6 A10 SER A 314 SER A 321 -1 N GLY A 320 O SER A 327 SHEET 7 A10 GLU A 275 ASN A 278 -1 N LEU A 277 O TRP A 315 SHEET 8 A10 MET A 268 GLN A 270 -1 N TYR A 269 O MET A 276 SHEET 9 A10 ARG A 261 ILE A 265 -1 N ILE A 265 O MET A 268 SHEET 10 A10 ALA A 302 ALA A 308 -1 O ALA A 308 N ARG A 261 SHEET 1 B 2 PHE A 60 GLU A 61 0 SHEET 2 B 2 LYS A 227 THR A 228 -1 O THR A 228 N PHE A 60 SHEET 1 C 2 THR A 147 ARG A 148 0 SHEET 2 C 2 LEU A 299 PRO A 300 -1 O LEU A 299 N ARG A 148 SHEET 1 D 2 GLY A 202 ARG A 204 0 SHEET 2 D 2 LYS A 207 VAL A 209 -1 O VAL A 209 N GLY A 202 LINK OG SER A 64 C7 AWY2 A 400 1555 1555 1.36 LINK OG SER A 64 C7 BWY2 A 400 1555 1555 1.34 CISPEP 1 TRP A 279 PRO A 280 0 -0.29 CISPEP 2 ASN A 305 PRO A 306 0 -0.26 SITE 1 AC1 12 SER A 64 GLN A 120 ASN A 152 TYR A 224 SITE 2 AC1 12 GLY A 320 SER A 321 THR A 322 GLY A 323 SITE 3 AC1 12 HOH A 501 HOH A 612 HOH A 639 HOH A 939 SITE 1 AC2 8 PRO A 181 LEU A 182 ASN A 245 VAL A 246 SITE 2 AC2 8 ALA A 247 ASP A 248 HOH A 692 HOH A 758 CRYST1 76.223 69.046 62.152 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013119 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014483 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016090 0.00000